Ara
Treatment
The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Implementation and workflow strategies for integrating digital therapeutics for alcohol use disorders into primary care: a qualitative study
Abstract
Background
Alcohol use disorders (AUD) are prevalent and often go untreated. Patients are commonly screened for AUD in primary care, but existing treatment programs are failing to meet demand. Digital therapeutics include novel...
Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are common...
Comparison of Treatments for Cocaine Use Disorder Among Adults
Key Points
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...
Cocaine Reading List
Cocaine is an addictive stimulant drug that originates from the leaves of the coca plant, which is indigenous to South America. The drug's effects include heightened alertness, attention, and energy, as well as feelings of euphoria and...
Responding to stimulant use — developments in treatment
Objective: To better understand current developments in the treatment of stimulant use.
Background: Stimulant drugs are second only to cannabis as the most widely used class of illicit drug globally, accounting for 68 million past-year...
Exploring treatment barriers on the use of crystal methamphetamine among young people in Zimbabwe
Substance misuse among young people is one of the most public concerns in global health. This study set out to explore treatment barriers among young people in Zimbabwe.
Data was collected through interviews with 30 participants
The study...
Trends in Overdose and Other Drug-Induced Deaths in Australia
This report presents the most recent and in-depth data on overdose and drug-induced deaths in Australia, covering the period 2002 to 2021. It is the most recent output in a series of annual publications on trends in drug overdose deaths...
Adolescent Substance Use and Risk Behaviours in the Mediterranean Region
Preface
The Council of Europe is the continent’s leading human rights organisation. It comprises 46 member states, 27 of which are members of the European Union. All Council of Europe member states have signed up to the European Convention...
Report: Colloquium on “Responding to the nexus between adverse childhood experiences and drug use”
A colloquium on “Responding to the Nexus between Adverse Childhood Experiences and Drug Use” was held on April 15, 2023 in New Delhi, attended by 40+ participants. The colloquium was hosted and organised by the Society for Promotion of Youth and Masses (SPYM) with the support of International Society of Substance Use Professionals (ISSUP) and Paul Hamlyn Foundation (PHF).
Ingestion of Illicit Substances by Young Children Before and During the COVID-19 Pandemic
Abstract
Importance Information about the trend in illicit substance ingestions among young children during the pandemic is limited.
Objectives To assess immediate and sustained changes in overall illicit substance ingestion rates among...
PTACC Annual Deflection Summit Call for International Presenters
Proposals are now being accepted for the 2023 Police, Treatment, and Community Collaborative’s (PTACC) National Deflection and Pre-arrest Diversion Summit.
All submissions must be uploaded by May 5, 2023 at 2:00 EDT in order to be...
Parenting interventions in the context of prevention: New guidelines and a call for action
ISSUP Lebanon present their Webinar on Parenting interventions in the context of prevention.
Early exposure to cannabis and long-lasting consequences in the brain
ISSUP Italy are pleased to present their Webinar on How early exposure to cannabis misshapes the brain and exerts long-lived effects.
Colloquium on “Responding to the Nexus between Adverse Childhood Experiences and Drug Use”
ISSUP India conducted a one-day colloquium titled “Responding to the Nexus between Adverse Childhood Experiences and Drug Use” with the support of the Paul Hamlyn Foundation and National Drug Dependence Treatment Centre, AIIMS on 15th April...
Stigma, Family and Community
ISSUP are pleased to present the Second Session in the Webinar Series on Stigma and Substance Use. The Second Session will be hosted by ISSUP Nigeria on the topic of 'Stigma, Family and Community'.
Normalisation of Prevention Principles and Practices to Reduce Substance Use Disorders Through an Integrated Dissemination and Implementation Framework
Major research breakthroughs over the past 30 years in the field of substance use prevention have served to:
(1) enhance understanding of pharmacological effects on the nervous systems and the health and social consequences of the use of...
Free Telementoring Mentoring Program Aims to Bring Research-Based Practices and Skills Related to Health Care Professionals Working with People who Use Alcohol
The Alcohol Use and Mental Health Project ECHO is a no-cost virtual program for health care professionals who are looking for up-to-date and research-based information on working with people who use alcohol.
The program, which is only in...
National Substance Use and Mental Health Services Survey (N-SUMHSS), 2021: Data on Substance Use and Mental Health Treatment Facilities
The N‑SUMHSS is a voluntary annual survey of all active substance use and mental health facilities in the United States, its territories, and D.C. The annual report presents findings on the general profile of substance use and mental health...
The 9th Anniversary of Ahsania Mission Women Drug Treatment Centre
Social stigma is the main obstacle for female substance users’ treatment.
Social stigma is the reason why females who use substances are unwilling to seek treatment. The rate of substance abuse among the female is frightfully increasing...
Cigarette/Nicotine use - a Gateway to other drug use?
ISSUP The Gambia are pleased to present their upcoming Webinar on Cigarette/Nicotine use.